End Cash: The amount of cash held by the company for the given period.
OnKure Therapeutics, Inc. (OKUR) had End Cash of $96.66M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-15.93M |
|
-- |
|
-- |
|
$17.00M |
|
$-17.00M |
|
$1.07M |
|
$-15.93M |
|
$-15.93M |
|
$-15.93M |
|
$-15.93M |
|
$-15.93M |
|
$-15.93M |
|
$-17.00M |
|
$-16.79M |
|
13.42M |
|
13.42M |
|
$-1.19 |
|
$-1.19 |
|
| Balance Sheet Financials | |
$98.17M |
|
$0.93M |
|
$1.71M |
|
$99.88M |
|
$8.79M |
|
-- |
|
$0.45M |
|
$9.23M |
|
$90.65M |
|
$90.65M |
|
$90.65M |
|
13.44M |
|
| Cash Flow Statement Financials | |
$-14.01M |
|
$-0.02M |
|
$-0.08M |
|
$110.76M |
|
|
End Cash |
$96.66M |
$-14.10M |
|
$2.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.57% |
|
-17.57% |
|
-15.94% |
|
-17.57% |
|
$6.74 |
|
$-1.04 |
|
$-1.04 |
|